Halozyme Therapeutics Inc (HALO)

[maumar]

I think that what is happening is that Darzalex Faspro and phesgo (and IV efga) continue to exceed expectations, the risk of a disastrous acquisition is out of the way, and there is more visibility into new products: SC Efga, SC Tecentriq, SC Opdivo, SC Ocrevus, Amivantamab in phase 3, and the potential of new deals with Enhanze and the auto injector, so Helen's talking about Halo's strong prospects sounds more realistic.

And of course, it doesn't hurt that, all of a sudden, biotechs are on fire right now.